China Artificial Intelligence (AI) In Healthcare Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     China Artificial Intelligence 
(AI) In Healthcare Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
A cc o r d i ng  t o  t h e  l a t e s t  r e p o r t  b y  I MA R C  Gr o u p ,  t i t l e d  " C h in a  A r t i f i c i a l  I n t e l l i g e n ce  
( A I )  I n  H e a l t h c a r e  M a r k e t :  I n d u s t r y  T r e n d s ,  S h a r e ,  S iz e ,  G r o wt h ,  O p p o r t u n i t y  a n d  
F o r e c a s t  2 0 2 4 - 2 0 32 , "  t h e  C h i n a  a r t i f i c i a l  i n te l l i g e n c e  ( A I )  i n  h e a l t h c a r e  m a r ke t  i s  
p r o j e c t ed  t o  ex h i b i t  a  g r o w t h  r a t e  ( C A GR )  o f  2 3 . 50 %  d u r i n g  20 2 4 - 2 03 2 .
T he  s t r a t e g i c  f o cu s  o f  t he  c o u n t r y  o n  t e ch n o l o g i ca l  i n no v a t i o n  as  w e l l  a s  i t s  p r e s s i ng  
Report de m a n d  t o  i m p ro v e  h e a l t h ca r e  d e l i v e ry  a re  t he  f ac t o r s  r e s po n s i b l e  f o r  t h e  g r ow t h  o f  
C h i n a  a r t i f i c i a l  i n t e l l i ge n c e  (A I )  i n  h e a l th c a r e  m a r ke t .  A d d i t i o na l l y ,  t h e  i n i t i a t i v e s  t a k e n  
by  g ov e r n me n t  a u t h o r i t i e s ,  s u ch  a s  t he  “ N e x t  G en e r a t i on  A r t i f i c i a l  I n t e l l i g e nc e  
Highlight and D ev e l o p me n t  P l a n , ”  em p h as i z e  A I ’ s  r o l e  i n  t r a n s f o r m i n g  h e a l t hc a r e  s e r v i c e s ,  
en c o u r ag i n g  s i gn i f i c a n t  i n v e s t me n t s  a n d  ad v a n ce m e n t s  i n  t h i s  s e c t o r .  
Description T he s e  i n i t i a t i v e s  a i m  t o  i m p ro v e  h ea l t h c a r e  a c c e ss i b i l i t y  a nd  q u a l i t y  b y  i n t e g ra t i n g  A I -d r i v e n  s o l u t i on s  i n  d i a g n o s t i c s ,  t r ea t m e n t  p l a n n i n g ,  a n d  p a t i e n t  m a n a ge m e n t .  
Mo r e o ve r ,  t h e  ag i n g  p o p u l a t i o n  a n d  r i s i n g  i n c i d e n c e  o f  c h r on i c  d i s e a s es  i n  C h i na  
c r e a t e  a  su b s t an t i a l  d e ma n d  f o r  e f f i c i en t  a n d  e f f e c t i v e  h e a l t h c a r e  s o l u t i o n s ,  f u r t he r  
d r i v i n g  t he  a d o p t i o n  o f  A I  t e c h n o l og i e s .
R eq u e s t  f o r  a  P D F  sa m p l e  o f  t h i s  re p o r t :  
h t t p s : / /w w w . i ma r c g r o u p . co m / ch i na - a r t i f i c i a l - i n te l l i g e n c e - i n - h ea l t h c a r e - m a rk e t / r eq u e s t sa
mp l e
Report Description
China  Ar t i f i c ia l  In te l l igence  (AI )  In  Hea l thcare  Market  Trends :
Techno log ica l  advancements  and  co l labora t ions  be tween  tech  g ian ts  and  hea l thcare  p rov ide rs  a re  a lso  key  
d r i ve rs  o f  t he  marke t .  Tech  compan ies  in  Ch ina  l i ke  Ba idu ,  A l ibaba ,  and  Tencen t  a re  heav i ly  inves t ing  in  A I  
hea l thcare  p ro jec ts ,  deve lop ing  soph is t i ca ted  a lgo r i t hms and  A I  p la t fo rms tha t  enhance  med ica l  imag ing ,  
p red ic t i ve  ana ly t i cs ,  and  persona l ized  med ic ine .  These  innova t ions  a re  t rans fo rming  how hea l thcare  p rov ide rs  
d iagnose  and  t rea t  d i seases ,  enab l ing  ear l i e r  de tec t ion  and  more  p rec ise  in te rven t ions .  
Fur the rmore ,  t he  in teg ra t ion  o f  A I  in  te lemed ic ine  and  remote  pa t ien t  mon i to r ing  is  becoming  inc reas ing ly  
p reva len t ,  espec ia l l y  i n  the  wake  o f  the  COVID-19  pandemic ,  wh ich  h igh l igh ted  the  need  fo r  con tac t less  
hea l thcare  se rv ices .  The  p ro l i f e ra t ion  o f  e lec t ron ic  hea l th  records  and  b ig  da ta  ana ly t i cs  suppor ts  the  A I  
hea l thcare  sec to r  by  p rov id ing  vas t  da tase ts  necessary  fo r  t ra in ing  A I  mode ls ,  wh ich  is  an t ic ipa ted  to  d r ive  Ch ina  
a r t i f i c ia l  i n te l l igence  (A I )  i n  hea l thcare  marke t  over  the  fo recas ted  per iod .
View Report  TOC,  F igures  and Tab les :  
h t tps : / /www. imarcgroup.com/china-ar t i f i c ia l - in te l l igence - in-hea l thcare-market
Off ering Insights:
• Hardware
• Software
• Services
 
Technology Insights:
Report • Machine Learning
• Context-Aware Computing
Segmentation
• Natural  Language Processing
• Others
Application Insights:
• Robot-Assisted Surgery
• Virtual  Nursing Assistant
• Administrat ive Workfl ow Assistance
• Fraud Detection
• Dosage Error Reduction
• Clinical  Tr ia l  Part ic ipant Identifi er
• Prel iminary Diagnosis
• Others
Report  
Segmentation End User Insights:
• Healthcare Providers
• Pharmaceut ical  and Biotechnology Companies
• Pat ients
• Others
Region Insights:
• North China
• East China
• South Central  China
• Southwest China
Report • Northwest China
• Northeast China
Segmentation
How has the China artificial intelligence (AI) in 
healthcare market performed so far and how will it 
perform in the coming years?
What has been the impact of COVID-19 on the China 
artificial intelligence (AI) in healthcare market?
Key 
What is the breakup of the China artificial intelligence 
Questions (AI) in healthcare market on the basis of offering?
Answered in 
What is the breakup of the China artificial intelligence 
the Report (AI) in healthcare market on the basis of technology?
What is the breakup of the China artificial intelligence 
(AI) in healthcare market on the basis of application?
What is the breakup of the China artificial intelligence 
(AI) in healthcare market on the basis of end user?
What are the various stages in the value chain of the 
China artificial intelligence (AI) in healthcare market?
What are the key driving factors and challenges in the 
China artificial intelligence (AI) in healthcare?
Key What is the structure of the China artificial intelligence 
(AI) in healthcare market and who are the key players?
Questions 
Answered in What is the degree of competition in the China artificial intelligence (AI) in healthcare market?
the Report
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
Contents 4     C h i n a  A r t i f i c i a l  I n t e l l i g e n c e  ( A I )  i n  H e a l t h c a r e  M a r k e t  –  I n t r o d u c t i o n4 . 1     O v e r v i e w
4 . 2     M a r k e t  D y n a m i c s
4 . 3     I n d u s t r y  T r e n d s
4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5     C h i n a  A r t i f i c i a l  I n t e l l i g e n c e  ( A I )  i n  H e a l t h c a r e  M a r k e t  L a n d s c a p e
5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
5 . 2     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6     C h i n a  A r t i f i c i a l  I n t e l l i g e n c e  ( A I )  i n  H e a l t h c a r e  M a r k e t  -  B r e a k u p  b y  
O f f e r i n g
6 . 1     H a r d w a r e
6 . 1 . 1     O v e r v i e w
6 . 1 . 2     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 . 1 . 4     M a r k e t  B r e a k u p  b y  T e c h n o l o g y
6 . 1 . 5     M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
       
6 .1 . 6     Ma r k e t  B r e a k u p  b y  E n d  U s e r  
6 .2     S o f t w a r e
6 .2 . 1     Ov e r v i e w
6 .2 . 2     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
6 .2 . 3     Ma r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6 .2 . 4     Ma r k e t  B r e a k u p  b y  T e c h n o l o g y
6 .2 . 5     Ma r k e t  B r e a k u p  b y  A p p l i c a t i o n  
6 .2 . 6     Ma r k e t  B r e a k u p  b y  E n d  U s e r  
6 .3     S e r v i c e s
6 .3 . 1     Ov e r v i e w
6 .3 . 2     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
Table of 6 .3 . 3     Ma r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )6 .3 . 4     Ma r k e t  B r e a k u p  b y  T e c h n o l o g y
6 .3 . 5     Ma r k e t  B r e a k u p  b y  A p p l i c a t i o n  
Contents 6 .3 . 6     Ma r k e t  B r e a k u p  b y  E n d  U s e r  6 .4     A t t r a c t i v e  I n v e s tm e n t  P r o p o s i t i o n  b y  O f f e r i n g
7     C h i n a  A r t i f i c i a l  I n t e l l i g e n c e  ( A I )  i n  H e a l t h c a r e  M a r k e t  -  
B r e a k u p  b y  T e c h n o lo g y
7 .1     Ma c h i n e  L e a r n i n g
7 .1 . 1     Ov e r v i e w
7 .1 . 2     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
7 .1 . 3     Ma r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7 .1 . 4     Ma r k e t  B r e a k u p  b y  O f f e r i n g
7 .1 . 5     Ma r k e t  B r e a k u p  b y  A p p l i c a t i o n
7 .1 . 6     Ma r k e t  B r e a k u p  b y  E n d  U s e r      
7 . 2     C o n te x t - A w a r e  C o m p u t i n g
7 .2 . 1     Ov e r v i e w
7 .2 . 2     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3
F o r  m o r e  i n f o r m a t io n ,  v i s i t :  
ht tps : / /www. imarcgroup .com/ch ina-ar t i fi c ia l - i n te l l igence - in -
hea l thcare -market / toc
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: